ArticleJournal of thoracic disease2025

Efficacy and safety of poly ADP-ribose polymerase inhibitors (PARPis) in extensive-stage small-cell lung cancer (ES-SCLC) treatment: a systematic review and meta-analysis.

Cong-Cong Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.